The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where it has already spent more than $3 billion, and will focus on producing plasma-derived therapies.
Categories:
Related Post
Wood Mackenzie sees extended ‘sunset’ for costly coal power
Coal is more expensive than gas or renewables in the United States, but a slowdown…
Construction prices ‘surged’ in April, up 6.2% year to date
Input prices have now risen more during the first four months of 2026 than over…
Stanley Black & Decker raises prices to mitigate tariff impacts
The company is also making supply chain moves to become more compliant with the U.S.-Mexico-Canada…